647 COMPLEX PERCUTANEOUS CORONARY INTERVENTION IN HIGHT BLEEDING AND THROMBOTIC RISK PATIENT: WHICH ANTITHROMBOTIC THERAPY?

نویسندگان

چکیده

Abstract Background Antiplatelet therapy is required in patients with atherosclerotic coronary artery disease (CAD) undergoing percutaneous intervention (PCI) drug-eluting stents (DES). Current European and American guidelines recommend 6 months of DAPT CCS 12 after ACS. However, a shorter duration may be considered high bleeding risk (HBR) patients, longer those at higher thrombotic (HTR). To minimize the events an individual patient therefore improve overall outcomes PCI, stratification essential. In particular, characteristics must weighed on case-by-case basis to tailor antiplatelet strategies decisions over patient's profile. We describe illustrative case complex PCI ACS which defining appropriate clinical challenge. Clinical A 68-year-old man ACS-NSTEMI anemia was hospitalized intensive care unit. His medical history notable for hypertension, dyslipidemia, diabetes mellitus, diabetic retinopathy, chronic kidney (CKD) paroxysmal atrial fibrillation. transthoracic echocardiogram showed left ventricular ejection fraction 30% diffuse hypokinesia, without relevant valvular disease. He conducted cath-lab diagnostic angiogram three-vessel critical CAD. After Heart Team evaluation bypass surgery (CABG) indicated. during hospitalization unit there worsening conditions cognitive impairment due mesencephalic stroke leading new assessment that indicated stabilization scenario. two weeks IVUS guided PCI. right performed implantation 1 DES (3.0/30 mm) middle segment (4.0/15 ostial segment. main bifurcation 2 (4.0/28 culotte technique. Patients have both HBR HTR, therefore, procedure, trade off model score introduced by Academic Research Consoritum (ARC) applied. Based his factor, predicted 1-y BARC type 3 5 (51.41%) greater than myocardial infarction or (25.00%). this result we decided prescribe Triple antithrombotic week, dual only oral anticoagulation. Conclusion context several factor mandatory define DAPT. The trade-off important useful tool identify who might benefit from individualized durations depending balance between HTR characteristics.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Antithrombotic therapy during percutaneous coronary intervention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

This chapter about antithrombotic therapy during percutaneous coronary intervention (PCI) is part of the seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy: Evidence Based Guidelines. Grade 1 recommendations are strong and indicate that the benefits do, or do not, outweigh risks, burden, and costs. Grade 2 suggests that individual patients' values may lead to different choices (...

متن کامل

Thrombotic Thrombocytopenic Purpura after Percutaneous Coronary Intervention

Thrombotic thrombocytopenic purpura (TTP) is a rapidly progressive hematological syndrome defined by the pentad of thrombocytopenia, microangiopathic hemolytic anemia, neurologic abnormalities, fever and renal dysfunction. TTP has been associated with major surgical procedures and specific medications. However, there is no known previously reported case in which acute TTP occurred after a percu...

متن کامل

Antithrombotic therapy during and after percutaneous coronary intervention in patients with atrial fibrillation.

A 64-year-old man has permanent atrial fibrillation and chronic hypertension. He has been treated with atenolol 50 mg daily, lisinopril 10 mg daily, and warfarin for the last 4 years. Otherwise, he is in good shape and employed full-time as a technical director of a large shipbuilding company. At a routine visit about 1 year ago, he complained of chest pain and dyspnea on exertion. An exercise ...

متن کامل

Safety and Efficacy of Dual Versus Triple Antithrombotic Therapy in Patients Undergoing Percutaneous Coronary Intervention.

BACKGROUND Choosing an antithrombotic regimen after coronary intervention in patients with concomitant indication for anticoagulation is a challenge commonly encountered by clinicians. METHODS We performed a meta-analysis of observational studies and randomized, controlled trials comparing outcomes of triple therapy (dual antiplatelet therapy and anticoagulant) with dual therapy (single antip...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: European Heart Journal Supplements

سال: 2022

ISSN: ['1520-765X', '1554-2815']

DOI: https://doi.org/10.1093/eurheartjsupp/suac121.346